Brief: Cereno Scientific And OCT Sign Contract For Phase II Study In Patients Undergoing Knee Replacement
12/09/2018 09:04
Sept 12 (Reuters) - Cereno Scientific AB CRNOSb.TE :
* CERENO SCIENTIFIC AND OCT SIGN CONTRACT FOR THE CONDUCT OF A PHASE II STUDY IN PATIENTS
UNDERGOING KNEE REPLACEMENT
* APPLICATIONS TO REGULATORY AUTHORITIES TO CONDUCT STUDY ARE EXPECTED TO BE SUBMITTED IN Q4
2018
Source text for Eikon: ID:nWkr1YBmBq
Further company coverage: CRNOSb.TE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Cereno Scientific AB
See all newsBrief: Cereno Scientific Carries Out Directed Share Issue Of SEK 60 Mln
Brief: Cereno Scientific Strengthens Patent Protection For Cs1 In Canada
Sweden's Cereno Scientific Q1 net loss widens amid clinical development
Brief: Cereno Scientific Q1 Loss After Financial Items SEK 28.6 Mln
Brief: Cereno Enters Collaboration With PHA Europe & Global